New hope for kidney patients battling depression
NCT ID NCT04422652
Summary
This study is testing two new treatment strategies for depression in people with chronic kidney disease (CKD). Researchers will compare a 16-week program of either a specific type of talk therapy (delivered remotely) or a non-SSRI antidepressant medication, with the option to add the other treatment if needed. The goal is to see if these approaches can safely reduce depression symptoms and improve quality of life, fatigue, and sleep for 201 adults with moderate-to-severe CKD and major depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Parkland Health and Hospital System
RECRUITINGDallas, Texas, 75235, United States
-
Stony Brook University Medical Center
NOT_YET_RECRUITINGStony Brook, New York, 11794-8430, United States
-
UT Southwestern and Affiliates
RECRUITINGDallas, Texas, 75390, United States
-
University of Washington
RECRUITINGSeattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.